Navigation Links
As Lipitor Lawsuits Progress, Bernstein Liebhard LLP Notes Publication of New Study Linking Statins to Cataract Development
Date:12/6/2014

(PRWEB) December 06, 2014

As hundreds of Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) that allege the medication caused Type 2 diabetes move through federal court, Bernstein Liebhard LLP notes the publication of a new study linking statins to the development of another serious side effect. According to a report from HealthDay News, Canadian researchers have revealed that the use of Lipitor and other statins may increase the risk for cataracts, a vision disorder that causes the lens of the eye to become cloudy.*

The study, which appears in the December issue of the Canadian Journal of Cardiology, looked at more than 207,000 adults with cataracts and more than 1.1 million without them. The research team found that patients who had taken statins for a year could face as much as a 27% increased risk for cataracts compared to those who did not use the medications. According to HealthDay News, the lead author of the study said that additional clinical trials are necessary to determine if, in fact, statins can cause cataracts.

"This research just serves to remind that statins may be associated with some serious health consequences, especially in light of the litigation involving Lipitor and diabetes that is currently underway in federal court,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case reviews to individuals who may have been harmed by Lipitor.

Lipitor Diabetes Litigation
Court documents indicate that more than 1,400 Lipitor lawsuits have been filed in a federal multidistrict litigation now underway in U.S. District Court, District of South Carolina, all of which accuse Pfizer Inc. of concealing information about the drug’s association with diabetes in order to protect sales of the medication. According to court documents, plaintiffs further allege that they would not have used Lipitor, or would have been more closely monitored for diabetes, had Pfizer’s warnings been sufficient. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)

The litigation involving Lipitor and diabetes has been growing since February 2012, when the U.S. Food & Drug Administration (FDA) announced that the labels for Lipitor and other statins would be updated to include new information about their potential association with Type 2 diabetes. The FDA announcement followed the publication of a study in JAMA: Internal Medicine the previous month which suggested that post-menopausal women treated with statins faced an increased risk of developing new-onset Type 2 diabetes. **

Type 2 diabetes patients who allegedly developed the disease due to their use of Lipitor may be able to pursue their own case against Pfizer. To learn more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

*consumer.healthday.com/eye-care-information-13/cataracts-health-news-116/could-your-daily-statin-raise-your-risk-for-cataracts-694356.html, HealthDay News, December 5, 2014
**archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.lipitorlawsuitcenter.com/
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/lipitor-lawsuit/lipitor-diabetes/prweb12376616.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes New Study Suggesting a Possible Alternative to Cholesterol-Lowering Statins
2. Lipitor Lawsuit Conference Scheduled for December, Bernstein Liebhard LLP Reports
3. Lipitor Lawsuits Move Forward, as Pfizer Seeks Dismissal of Texas Diabetes Claims Pending in Multidistrict Litigation, Bernstein Liebhard LLP Reports
4. As Lipitor Lawsuits Move Forward, Bernstein Liebhard LLP Notes New Study Suggesting an Association Between Type 2 Diabetes and Stain Use
5. Lipitor Lawsuit News: New Case Management Order Issued in Federal Lipitor Litigation, Bernstein Liebhard LLP Reports
6. Lipitor Lawsuits Move Forward, as Discovery Proceeds in Federal Multidistrict Litigation, Bernstein Liebhard LLP Reports
7. South Carolina Litigation Adds 200 Lipitor Lawsuits in a Month, as Plaintiffs File Suits Alleging New-Onset Diabetes, Bernstein Liebhard LLP Reports
8. Lipitor Lawsuit News: Bernstein Liebhard LLP Notes Growing Number of Type 2 Diabetes Claims in Federal Lipitor Litigation
9. Lipitor Lawsuits Continue to Be Filed in South Carolina Litigation, Bernstein Liebhard LLP Reports
10. Lipitor Lawsuits Move Forward With Scheduling Of First Bellwether Trial
11. Lipitor Lawsuit News: Pfizer, Inc. Named in Whistleblower Lawsuit Alleging Improper Marketing of Lipitor, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2018)... ... October 17, 2018 , ... The Jacobs & Cushman San ... of Food Banks at a meeting of its Board of Directors. , California ... the State of California. CAFB provides its member food banks with a range of ...
(Date:10/16/2018)... ... 16, 2018 , ... Balboa Capital , a leading ... franchise financing , is now recognized by Massage Envy as an Approved Lender ... deliver custom-tailored financing programs to Massage Envy franchisees who need funding for furniture, ...
(Date:10/16/2018)... ... ... dicentra Global Certifications, an affiliate of dicentra Cannabis Consulting, has announced the ... first G7 country in the world to formally legalize the recreational production and use ... production and use of cannabis edibles. , More than one in four Canadians aged ...
(Date:10/16/2018)... ... October 16, 2018 , ... The months of training are over. The race has come and ... feel like they were put through the wringer after the big event. Read on for ... Medicine in Motion on how to treat the body and mind after a long run: ...
(Date:10/13/2018)... ... October 12, 2018 , ... Convoy of Hope is ... trucks and a disaster service team to the devastated Florida Panhandle to begin response ... to help Convoy’s disaster response teams and provide supplies to those affected by the ...
Breaking Medicine News(10 mins):
(Date:10/16/2018)... ... October 16, 2018 , ... ... the development and marketing of algae-based omega-3 products, Ben Kelly of Algarithm Ingredients ... Summit in Houston, Texas on October 15. The title of their presentation was ...
(Date:10/13/2018)... ... October 12, 2018 , ... Submissions to the ... from healthcare providers, students, trainees, and researchers worldwide. Winning proposals will receive grants ... and bioinformatics services. , “uBiome is thrilled to further expand our collaborations in ...
(Date:10/11/2018)... ... October 11, 2018 , ... doeLEGAL, a leading provider of ... law firms, today announced it is sponsoring the 2018 ACC Annual Meeting in ... corporate legal departments are using smart data, intelligently delivered to rethink data strategies ...
Breaking Medicine Technology: